Drug treatment options in preeclampsia are limited because some antihypertensive drugs, such as angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor (AT1) antagonists (sartans), have shown teratogenic effects on the fetus [15]. This evidence concerns the gene ACE and preeclampsia.